Non-statin users also had lower body mass indexes and waist circumferences and a lower proportion of cardiovascular comorbidities, including hypertension, chronic kidney disease, cardiovascular disease, prolonged diabetes mellitus, and the use of insulin or multiple oral hypoglycemic agents. The gene discussed is INS; the disease is cardiovascular disorder.